| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.72B | 35.62B | 30.93B | 22.51B | 27.32B | 17.63B |
| Gross Profit | 8.65B | 7.77B | 5.78B | 4.77B | 6.25B | 2.88B |
| EBITDA | 8.24B | 6.82B | 4.30B | 5.78B | 7.19B | 3.08B |
| Net Income | 1.74B | 1.23B | -2.23B | 857.70M | 2.42B | 217.82M |
Balance Sheet | ||||||
| Total Assets | 71.82B | 72.18B | 74.22B | 83.29B | 77.98B | 77.10B |
| Cash, Cash Equivalents and Short-Term Investments | 21.54B | 21.21B | 16.58B | 16.98B | 26.87B | 21.90B |
| Total Debt | 20.87B | 21.36B | 25.37B | 33.22B | 28.05B | 33.20B |
| Total Liabilities | 28.75B | 29.91B | 33.90B | 41.61B | 37.78B | 39.65B |
| Stockholders Equity | 36.84B | 36.24B | 35.18B | 37.55B | 36.91B | 34.62B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.47B | 7.34B | -14.25B | 11.38B | -5.33B |
| Operating Cash Flow | 0.00 | 15.43B | 10.90B | -12.45B | 13.16B | -1.45B |
| Investing Cash Flow | 0.00 | -6.72B | -3.38B | -2.54B | -2.64B | -3.93B |
| Financing Cash Flow | 0.00 | -4.27B | -7.93B | 4.91B | -5.01B | 4.91B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥75.30B | 17.55 | ― | 2.22% | 5.92% | 20.63% | |
74 Outperform | ¥43.19B | 17.21 | ― | 1.95% | 16.36% | 38.48% | |
72 Outperform | ¥36.47B | 21.54 | ― | 0.93% | 10.22% | ― | |
64 Neutral | ¥25.56B | 24.81 | ― | 3.56% | -5.25% | -4.95% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥15.51B | 22.11 | ― | ― | 14.37% | -44.67% | |
61 Neutral | ¥27.64B | 24.31 | ― | 1.85% | 4.17% | -20.08% |